This announcement is a separate document:
大洋生物:浙江大洋生物科技集团股份有限公司监事会关于公司2024年员工持股计划相关事项的审核意见
Zhejiang Dayang Biotech Group: The Supervisory Committee of Zhejiang Dayang Biotech Group Co., Ltd. reviewed and approved the 2024 Employee Stock Ownership Plan of the company.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.